Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Oncotarget|December 20, 2017
High mobility group protein B1 is a predictor of poor survival in ovarian cancerLee R Machado, Paul M Moseley, Robert Moss, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?Ekaterina S Jordanova, Arko Gorter, Ouissam Ayachi, et al.Scientific Reports|April 13, 2024
Probing the expression and adhesion of glycans involved in Helicobacter pylori infectionDaniel Sijmons, Simon Collett, Caroline Soliman, et al.International Journal of Cancer|April 8, 2004
Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2Judith M Ramage, Rachael Metheringham, Andrew Conn, et al.Journal for Immunotherapy of Cancer|February 10, 2022
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapyRuhul H Choudhury, Peter Symonds, Samantha J Paston, et al.Journal for Immunotherapy of Cancer|October 19, 2023
Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunitySabaria Shah, Katherine W Cook, Peter Symonds, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Monoclonal Antibodies Targeting LecLex-Related Glycans with Potent Antitumor ActivityJia Xin Chua, Mireille Vankemmelbeke, Richard S McIntosh, et al.Journal for Immunotherapy of Cancer|March 12, 2022
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancerTheodoros Michelakos, Filippos Kontos, Tomohiro Kurokawa, et al.Oncoimmunology|May 10, 2019
T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapyVictoria A Brentville, Peter Symonds, Katherine W Cook, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55Gustav J Ullenhag, Ian Spendlove, Nicholas F S Watson, et al.Pageof 8